Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 2 | 25 | 2023 | 269 | 5.060 |
Why?
|
Cytoskeletal Proteins | 18 | 2018 | 1326 | 2.150 |
Why?
|
Neurofibromatosis 2 | 13 | 2023 | 387 | 1.830 |
Why?
|
Cytoskeleton | 11 | 2018 | 1178 | 1.340 |
Why?
|
Neurilemmoma | 5 | 2023 | 522 | 0.990 |
Why?
|
Contact Inhibition | 3 | 2015 | 46 | 0.950 |
Why?
|
Morphogenesis | 4 | 2021 | 746 | 0.860 |
Why?
|
Cell Polarity | 4 | 2014 | 637 | 0.780 |
Why?
|
Ephrins | 1 | 2021 | 28 | 0.750 |
Why?
|
Organogenesis | 2 | 2018 | 214 | 0.750 |
Why?
|
Neurofibromatosis 1 | 5 | 2014 | 561 | 0.680 |
Why?
|
Cell Proliferation | 9 | 2018 | 10455 | 0.670 |
Why?
|
Microfilament Proteins | 7 | 2015 | 1130 | 0.650 |
Why?
|
Cell Membrane | 11 | 2018 | 3642 | 0.640 |
Why?
|
Actomyosin | 2 | 2018 | 114 | 0.630 |
Why?
|
Epidermal Growth Factor | 2 | 2018 | 697 | 0.620 |
Why?
|
Pinocytosis | 1 | 2018 | 63 | 0.620 |
Why?
|
Signal Transduction | 18 | 2021 | 23621 | 0.580 |
Why?
|
Cell Communication | 3 | 2018 | 1660 | 0.570 |
Why?
|
Adherens Junctions | 2 | 2010 | 90 | 0.560 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2018 | 304 | 0.540 |
Why?
|
Neurofibromin 1 | 4 | 2012 | 190 | 0.540 |
Why?
|
Genes, Neurofibromatosis 2 | 8 | 2009 | 122 | 0.520 |
Why?
|
Membrane Proteins | 13 | 2015 | 7868 | 0.500 |
Why?
|
Sodium Channels | 6 | 1993 | 339 | 0.470 |
Why?
|
Intestinal Mucosa | 3 | 2012 | 3043 | 0.460 |
Why?
|
Actins | 4 | 2018 | 2059 | 0.460 |
Why?
|
Phosphoproteins | 5 | 2010 | 2448 | 0.440 |
Why?
|
Basement Membrane | 1 | 2014 | 348 | 0.430 |
Why?
|
GTPase-Activating Proteins | 2 | 2014 | 467 | 0.410 |
Why?
|
Cafe-au-Lait Spots | 1 | 2012 | 20 | 0.410 |
Why?
|
Homeostasis | 3 | 2018 | 3345 | 0.400 |
Why?
|
Animals | 58 | 2023 | 168965 | 0.350 |
Why?
|
Epithelial Cells | 4 | 2014 | 3698 | 0.350 |
Why?
|
Integrins | 1 | 2014 | 840 | 0.330 |
Why?
|
Mice | 42 | 2023 | 81912 | 0.330 |
Why?
|
Nervous System Neoplasms | 2 | 2007 | 91 | 0.320 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2428 | 0.320 |
Why?
|
Schwann Cells | 4 | 2023 | 195 | 0.310 |
Why?
|
Neurofibroma | 1 | 2009 | 95 | 0.310 |
Why?
|
Transcription Factors | 3 | 2018 | 12158 | 0.290 |
Why?
|
Neoplasms | 9 | 2018 | 22350 | 0.290 |
Why?
|
Proteome | 1 | 2018 | 1890 | 0.290 |
Why?
|
Epidermis | 1 | 2010 | 539 | 0.290 |
Why?
|
Stem Cells | 2 | 2010 | 3535 | 0.270 |
Why?
|
Intercellular Junctions | 2 | 2018 | 198 | 0.270 |
Why?
|
Genes, Tumor Suppressor | 2 | 2023 | 1058 | 0.260 |
Why?
|
Protein Transport | 3 | 2021 | 1944 | 0.260 |
Why?
|
Cell Adhesion | 7 | 2014 | 3093 | 0.250 |
Why?
|
Hepatomegaly | 2 | 2018 | 84 | 0.240 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1621 | 0.230 |
Why?
|
Disease Models, Animal | 11 | 2014 | 18330 | 0.230 |
Why?
|
Epithelium | 1 | 2009 | 1606 | 0.230 |
Why?
|
Myotonia Congenita | 3 | 1992 | 16 | 0.230 |
Why?
|
Failure to Thrive | 1 | 2004 | 139 | 0.220 |
Why?
|
Nerve Sheath Neoplasms | 2 | 2004 | 169 | 0.210 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4892 | 0.200 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2887 | 0.200 |
Why?
|
Osteosarcoma | 4 | 2008 | 910 | 0.200 |
Why?
|
Gene Silencing | 2 | 2007 | 1505 | 0.190 |
Why?
|
Repressor Proteins | 1 | 2012 | 2979 | 0.190 |
Why?
|
Rhabdomyosarcoma | 1 | 2004 | 358 | 0.180 |
Why?
|
rac GTP-Binding Proteins | 1 | 2001 | 163 | 0.180 |
Why?
|
Neoplasms, Experimental | 4 | 2004 | 1228 | 0.170 |
Why?
|
Neurofibromatoses | 2 | 2014 | 303 | 0.170 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2001 | 133 | 0.170 |
Why?
|
Microvilli | 4 | 2010 | 235 | 0.160 |
Why?
|
Neoplasm Invasiveness | 3 | 2011 | 3611 | 0.160 |
Why?
|
Mechanotransduction, Cellular | 2 | 2015 | 539 | 0.160 |
Why?
|
Mammary Glands, Human | 1 | 2020 | 201 | 0.160 |
Why?
|
Blood Proteins | 2 | 2003 | 1190 | 0.160 |
Why?
|
Paracrine Communication | 1 | 2020 | 277 | 0.160 |
Why?
|
Gene Deletion | 3 | 2018 | 2668 | 0.150 |
Why?
|
Cells, Cultured | 6 | 2020 | 18989 | 0.150 |
Why?
|
Gastrula | 1 | 1997 | 83 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9612 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2003 | 2843 | 0.140 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 420 | 0.130 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 1992 | 781 | 0.130 |
Why?
|
Mutation | 11 | 2023 | 30211 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2010 | 4357 | 0.130 |
Why?
|
Paralyses, Familial Periodic | 2 | 1992 | 13 | 0.130 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2015 | 28 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2800 | 0.120 |
Why?
|
Skin | 1 | 2009 | 4499 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 2012 | 1612 | 0.120 |
Why?
|
Genes, Neurofibromatosis 1 | 2 | 2007 | 75 | 0.120 |
Why?
|
Liver | 1 | 2010 | 7578 | 0.120 |
Why?
|
Ornithine-Oxo-Acid Transaminase | 3 | 1990 | 49 | 0.120 |
Why?
|
Mesothelioma | 2 | 2014 | 774 | 0.120 |
Why?
|
Gyrate Atrophy | 2 | 1990 | 16 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 5 | 1992 | 377 | 0.110 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2014 | 120 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 1 | 2009 | 3186 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2018 | 14476 | 0.110 |
Why?
|
Protein Binding | 2 | 2021 | 9327 | 0.110 |
Why?
|
Brain Chemistry | 3 | 1993 | 951 | 0.110 |
Why?
|
Humans | 54 | 2023 | 767040 | 0.110 |
Why?
|
Cell Membrane Structures | 1 | 2012 | 24 | 0.100 |
Why?
|
Quinazolines | 2 | 2010 | 1369 | 0.100 |
Why?
|
Catenins | 1 | 2012 | 44 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4282 | 0.100 |
Why?
|
B-Lymphocyte Subsets | 1 | 2013 | 240 | 0.100 |
Why?
|
Neoplasm Proteins | 3 | 2000 | 3599 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2013 | 11657 | 0.100 |
Why?
|
Caco-2 Cells | 1 | 2012 | 364 | 0.100 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3427 | 0.100 |
Why?
|
Molecular Sequence Data | 14 | 2003 | 17608 | 0.100 |
Why?
|
Centrosome | 1 | 2012 | 209 | 0.090 |
Why?
|
Receptors, Growth Factor | 1 | 2012 | 324 | 0.090 |
Why?
|
Genes, p53 | 4 | 2005 | 711 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 2018 | 2093 | 0.090 |
Why?
|
Mice, Transgenic | 4 | 2011 | 9551 | 0.090 |
Why?
|
Histological Techniques | 1 | 2011 | 193 | 0.090 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2011 | 147 | 0.090 |
Why?
|
Muscles | 2 | 1993 | 1576 | 0.090 |
Why?
|
alpha Catenin | 1 | 2010 | 37 | 0.090 |
Why?
|
Cell Movement | 2 | 2018 | 5203 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1673 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2013 | 5499 | 0.090 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2013 | 546 | 0.090 |
Why?
|
Base Sequence | 13 | 2008 | 12414 | 0.090 |
Why?
|
Research | 2 | 2014 | 1977 | 0.080 |
Why?
|
Muscle Proteins | 2 | 1993 | 1160 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 2902 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2875 | 0.080 |
Why?
|
RNA Interference | 2 | 2015 | 2829 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 685 | 0.080 |
Why?
|
Immunity, Humoral | 1 | 2013 | 610 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2010 | 3440 | 0.080 |
Why?
|
Alleles | 4 | 2001 | 6893 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2011 | 874 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 152 | 0.080 |
Why?
|
Muscular Diseases | 1 | 1992 | 552 | 0.070 |
Why?
|
Cold Temperature | 1 | 1992 | 793 | 0.070 |
Why?
|
Immunoblotting | 1 | 2011 | 1647 | 0.070 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 857 | 0.070 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2008 | 83 | 0.070 |
Why?
|
Ear Neoplasms | 1 | 2008 | 118 | 0.070 |
Why?
|
Cadherins | 1 | 2012 | 903 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1168 | 0.070 |
Why?
|
Cell Compartmentation | 1 | 2007 | 383 | 0.070 |
Why?
|
Drug Design | 1 | 2012 | 1045 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2472 | 0.070 |
Why?
|
Ceramides | 1 | 2008 | 202 | 0.070 |
Why?
|
DNA | 6 | 1993 | 7210 | 0.070 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2011 | 754 | 0.070 |
Why?
|
Keratinocytes | 1 | 2010 | 876 | 0.060 |
Why?
|
Solubility | 1 | 2007 | 1078 | 0.060 |
Why?
|
RNA Splicing | 1 | 1990 | 903 | 0.060 |
Why?
|
Nerve Tissue Proteins | 3 | 2001 | 4401 | 0.060 |
Why?
|
Mutant Proteins | 1 | 2007 | 487 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 1990 | 1384 | 0.060 |
Why?
|
Peripheral Nervous System | 1 | 2007 | 151 | 0.060 |
Why?
|
Skin Neoplasms | 3 | 2014 | 5859 | 0.060 |
Why?
|
Thymus Gland | 1 | 2010 | 1264 | 0.060 |
Why?
|
Pigment Epithelium of Eye | 1 | 2005 | 209 | 0.060 |
Why?
|
Amino Acid Sequence | 6 | 2001 | 13411 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 17097 | 0.060 |
Why?
|
Stem Cell Niche | 1 | 2008 | 347 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2020 | 3610 | 0.060 |
Why?
|
Cholangiocarcinoma | 1 | 2010 | 561 | 0.060 |
Why?
|
3T3 Cells | 3 | 2001 | 1081 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2927 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2551 | 0.060 |
Why?
|
Cell Line | 4 | 2020 | 15567 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2012 | 9245 | 0.060 |
Why?
|
Cochlear Implantation | 1 | 2008 | 317 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2010 | 2330 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3738 | 0.050 |
Why?
|
rap GTP-Binding Proteins | 1 | 2003 | 24 | 0.050 |
Why?
|
Endocytosis | 1 | 2007 | 951 | 0.050 |
Why?
|
Consensus | 2 | 2011 | 3207 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 6106 | 0.050 |
Why?
|
Acute-Phase Proteins | 1 | 2004 | 251 | 0.050 |
Why?
|
Heterozygote | 2 | 2001 | 2794 | 0.050 |
Why?
|
Polymorphism, Genetic | 5 | 1992 | 4247 | 0.050 |
Why?
|
Hepatocyte Growth Factor | 1 | 2004 | 268 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3052 | 0.050 |
Why?
|
Animals, Newborn | 2 | 2005 | 2677 | 0.050 |
Why?
|
rho GTP-Binding Proteins | 1 | 2003 | 279 | 0.050 |
Why?
|
Phosphorylation | 4 | 2013 | 8310 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11063 | 0.050 |
Why?
|
Genes, Regulator | 1 | 2003 | 373 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2008 | 783 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2010 | 3511 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2003 | 192 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 3 | 2014 | 5693 | 0.050 |
Why?
|
Clinical Trials as Topic | 4 | 2014 | 8048 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1667 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2011 | 8628 | 0.050 |
Why?
|
Exons | 3 | 1992 | 2391 | 0.050 |
Why?
|
Models, Biological | 2 | 2007 | 9464 | 0.050 |
Why?
|
Pedigree | 4 | 1992 | 4539 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 1814 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2001 | 187 | 0.040 |
Why?
|
Down-Regulation | 1 | 2007 | 2931 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3760 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4787 | 0.040 |
Why?
|
Cell Lineage | 1 | 2009 | 2575 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2055 | 0.040 |
Why?
|
Mammals | 1 | 2005 | 1135 | 0.040 |
Why?
|
Models, Animal | 2 | 2004 | 2121 | 0.040 |
Why?
|
Cyclin D | 2 | 2011 | 71 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1518 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1893 | 0.040 |
Why?
|
Biomimetics | 1 | 2020 | 168 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3944 | 0.040 |
Why?
|
Hybrid Cells | 3 | 1993 | 421 | 0.040 |
Why?
|
Phenotype | 4 | 2020 | 16718 | 0.040 |
Why?
|
Cloning, Molecular | 3 | 1993 | 4167 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4473 | 0.040 |
Why?
|
RNA, Messenger | 2 | 1990 | 12793 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2013 | 22361 | 0.040 |
Why?
|
Cell Survival | 2 | 2008 | 5750 | 0.040 |
Why?
|
Sequence Alignment | 2 | 1992 | 2176 | 0.040 |
Why?
|
Gene Targeting | 2 | 2000 | 841 | 0.040 |
Why?
|
Fibroblasts | 1 | 2007 | 4167 | 0.030 |
Why?
|
Homozygote | 2 | 2003 | 1774 | 0.030 |
Why?
|
Apoptosis | 4 | 2014 | 9513 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2002 | 935 | 0.030 |
Why?
|
Fetus | 1 | 2004 | 1878 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 904 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 3408 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1991 | 766 | 0.030 |
Why?
|
Huntington Disease | 2 | 1992 | 1147 | 0.030 |
Why?
|
DNA Mutational Analysis | 3 | 2008 | 4114 | 0.030 |
Why?
|
Gene Expression | 4 | 2001 | 7587 | 0.030 |
Why?
|
Meningioma | 3 | 2011 | 1219 | 0.030 |
Why?
|
Genetic Linkage | 2 | 1992 | 2342 | 0.030 |
Why?
|
Mutagenesis | 1 | 1998 | 1227 | 0.030 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2014 | 146 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 13650 | 0.030 |
Why?
|
Gamma Rays | 1 | 1994 | 324 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 1992 | 4616 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10254 | 0.030 |
Why?
|
Fibrosarcoma | 1 | 1994 | 313 | 0.030 |
Why?
|
Polymerase Chain Reaction | 5 | 1992 | 6067 | 0.030 |
Why?
|
Transfection | 3 | 2014 | 5753 | 0.030 |
Why?
|
Amyloid | 2 | 1988 | 849 | 0.030 |
Why?
|
Sequence Tagged Sites | 1 | 1992 | 96 | 0.030 |
Why?
|
Oocytes | 2 | 1993 | 1168 | 0.020 |
Why?
|
Xenopus | 1 | 1993 | 710 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1992 | 418 | 0.020 |
Why?
|
G2 Phase | 1 | 2011 | 134 | 0.020 |
Why?
|
Mice, Nude | 3 | 2010 | 3618 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4280 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2003 | 1057 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 1992 | 437 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2011 | 2061 | 0.020 |
Why?
|
Hemoglobinopathies | 1 | 1990 | 101 | 0.020 |
Why?
|
S Phase | 1 | 2011 | 424 | 0.020 |
Why?
|
Hyperkalemia | 1 | 1992 | 233 | 0.020 |
Why?
|
Auditory Brain Stem Implants | 1 | 2009 | 33 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2599 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13491 | 0.020 |
Why?
|
Sequence Deletion | 2 | 2008 | 1494 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 812 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 380 | 0.020 |
Why?
|
Forecasting | 1 | 1998 | 2936 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 592 | 0.020 |
Why?
|
Immunological Synapses | 1 | 2009 | 58 | 0.020 |
Why?
|
Kinetics | 2 | 1993 | 6287 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 9108 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2003 | 1751 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2008 | 351 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4424 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1903 | 0.020 |
Why?
|
Pyridoxine | 1 | 1988 | 108 | 0.020 |
Why?
|
Genetic Techniques | 1 | 1990 | 427 | 0.020 |
Why?
|
Doxorubicin | 1 | 1994 | 2229 | 0.020 |
Why?
|
Rats | 3 | 2011 | 23713 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9532 | 0.020 |
Why?
|
Audiometry, Pure-Tone | 1 | 2008 | 210 | 0.020 |
Why?
|
Transaminases | 1 | 1988 | 198 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 740 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 569 | 0.020 |
Why?
|
Point Mutation | 1 | 1992 | 1591 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1743 | 0.020 |
Why?
|
Auditory Threshold | 1 | 2008 | 369 | 0.020 |
Why?
|
Up-Regulation | 2 | 2010 | 4143 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1825 | 0.020 |
Why?
|
Meningeal Neoplasms | 2 | 2009 | 1253 | 0.020 |
Why?
|
Telomere | 1 | 1992 | 943 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1349 | 0.020 |
Why?
|
Asbestos, Crocidolite | 1 | 2005 | 18 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 2005 | 49 | 0.020 |
Why?
|
Haplotypes | 1 | 1992 | 2722 | 0.020 |
Why?
|
Female | 6 | 2020 | 396660 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3608 | 0.020 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2005 | 84 | 0.020 |
Why?
|
Male | 7 | 2010 | 364203 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40154 | 0.020 |
Why?
|
Vestibular Diseases | 1 | 2008 | 232 | 0.020 |
Why?
|
Cyclins | 1 | 2007 | 605 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2007 | 545 | 0.020 |
Why?
|
Stromal Cells | 1 | 2010 | 1335 | 0.010 |
Why?
|
Cochlear Implants | 1 | 2009 | 342 | 0.010 |
Why?
|
Photoreceptor Cells | 1 | 2005 | 234 | 0.010 |
Why?
|
Macromolecular Substances | 2 | 2000 | 1430 | 0.010 |
Why?
|
Spleen | 1 | 2010 | 2292 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1988 | 750 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1331 | 0.010 |
Why?
|
Gene Expression Regulation | 3 | 2007 | 11923 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 1988 | 413 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 627 | 0.010 |
Why?
|
Protein Precursors | 1 | 1988 | 1134 | 0.010 |
Why?
|
Prevalence | 1 | 2001 | 15851 | 0.010 |
Why?
|
Genes | 1 | 1987 | 1824 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6507 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2008 | 800 | 0.010 |
Why?
|
Osteoblasts | 1 | 2008 | 1145 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.010 |
Why?
|
Radiosurgery | 1 | 2011 | 1330 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10748 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2592 | 0.010 |
Why?
|
Models, Molecular | 1 | 1992 | 5388 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2010 | 2056 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1504 | 0.010 |
Why?
|
Protein Kinases | 1 | 2007 | 1610 | 0.010 |
Why?
|
Sirolimus | 1 | 2007 | 1539 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 705 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2627 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2568 | 0.010 |
Why?
|
Genes, Insect | 1 | 2000 | 265 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2000 | 348 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 2457 | 0.010 |
Why?
|
Insect Proteins | 1 | 2000 | 253 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 1559 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2745 | 0.010 |
Why?
|
Drug Resistance | 2 | 1994 | 1592 | 0.010 |
Why?
|
Hamartoma | 1 | 2000 | 235 | 0.010 |
Why?
|
Threonine | 1 | 1998 | 272 | 0.010 |
Why?
|
G1 Phase | 1 | 1998 | 403 | 0.010 |
Why?
|
Mosaicism | 1 | 2000 | 480 | 0.010 |
Why?
|
Neuroma, Acoustic | 1 | 2000 | 455 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8535 | 0.010 |
Why?
|
Alzheimer Disease | 2 | 1988 | 8717 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6210 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2000 | 1716 | 0.010 |
Why?
|
Gene Frequency | 2 | 1992 | 3621 | 0.010 |
Why?
|
Goals | 1 | 2000 | 717 | 0.010 |
Why?
|
Serine | 1 | 1998 | 828 | 0.010 |
Why?
|
Cataract | 1 | 2000 | 837 | 0.010 |
Why?
|
Retinal Diseases | 1 | 2000 | 709 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 2000 | 714 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1474 | 0.010 |
Why?
|
RNA, Complementary | 1 | 1993 | 46 | 0.010 |
Why?
|
Age of Onset | 1 | 2000 | 3344 | 0.010 |
Why?
|
Metaphase | 1 | 1992 | 143 | 0.010 |
Why?
|
Cell Death | 1 | 1998 | 1677 | 0.010 |
Why?
|
Chromosomes, Fungal | 1 | 1992 | 110 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 1994 | 476 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2008 | 3626 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 848 | 0.010 |
Why?
|
HeLa Cells | 1 | 1998 | 3073 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 167 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2000 | 1722 | 0.010 |
Why?
|
RNA Probes | 1 | 1990 | 110 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 775 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1994 | 2012 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2003 | 2563 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 541 | 0.010 |
Why?
|
Ribonuclease, Pancreatic | 1 | 1990 | 112 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5716 | 0.010 |
Why?
|
Adult | 3 | 2000 | 223317 | 0.010 |
Why?
|
Globins | 1 | 1990 | 405 | 0.010 |
Why?
|
Membrane Potentials | 1 | 1993 | 1085 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 1065 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1991 | 351 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 1994 | 862 | 0.010 |
Why?
|
Genetic Counseling | 1 | 1992 | 635 | 0.000 |
Why?
|
In Situ Hybridization | 1 | 1992 | 1892 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2000 | 4925 | 0.000 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1988 | 174 | 0.000 |
Why?
|
Genetic Markers | 1 | 1992 | 2602 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1305 | 0.000 |
Why?
|
Genotype | 1 | 2000 | 13035 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 18063 | 0.000 |
Why?
|
RNA | 1 | 1993 | 2715 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13646 | 0.000 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1988 | 1117 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 65295 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36582 | 0.000 |
Why?
|
Down Syndrome | 1 | 1988 | 916 | 0.000 |
Why?
|
Genome, Human | 1 | 1992 | 4441 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1992 | 14672 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9410 | 0.000 |
Why?
|
Amyloid beta-Peptides | 1 | 1987 | 3886 | 0.000 |
Why?
|
Middle Aged | 1 | 2008 | 223233 | 0.000 |
Why?
|
Prognosis | 1 | 1994 | 29963 | 0.000 |
Why?
|
Brain | 1 | 1988 | 27163 | 0.000 |
Why?
|